Published in J Mol Cell Cardiol on October 01, 1981
Functional compartmentation of glycolytic versus oxidative metabolism in isolated rabbit heart. J Clin Invest (1985) 2.05
Metabolic compartmentation and substrate channelling in muscle cells. Role of coupled creatine kinases in in vivo regulation of cellular respiration--a synthesis. Mol Cell Biochem (1995) 1.49
Metabolic compartmentation - a system level property of muscle cells: real problems of diffusion in living cells. Int J Mol Sci (2008) 1.01
Renal and liver functions and muscle injuries during training and after competition in Thai boxers. Br J Sports Med (1998) 1.01
Myocardial ischemia--metabolic pathways and implications of increased glycolysis. Cardiovasc Drugs Ther (1990) 0.95
Functional interaction between K(ATP) channels and the Na(+)-K(+) pump in metabolically inhibited heart cells of the guinea-pig. J Physiol (1996) 0.92
2-Deoxyglucose and cytochalasin D modulate aldolase mobility in living 3T3 cells. J Cell Biol (1992) 0.90
Modeling of spatial metabolite distributions in the cardiac sarcomere. Biophys J (2007) 0.89
Relationship between myocardial metabolites and contractile abnormalities during graded regional ischemia. Phosphorus-31 nuclear magnetic resonance studies of porcine myocardium in vivo. J Clin Invest (1990) 0.85
Relationship between calcium loading and impaired energy metabolism during Na+, K+ pump inhibition and metabolic inhibition in cultured neonatal rat cardiac myocytes. J Clin Invest (1989) 0.82
Role of calcium and other ions in reperfusion injury. Cardiovasc Drugs Ther (1991) 0.80
Hypoxia and glucose independently regulate the beta-adrenergic receptor-adenylate cyclase system in cardiac myocytes. J Clin Invest (1991) 0.78
Ultrastructural correlates of ischaemic contracture during global subtotal ischaemia in the rat heart. J Exp Pathol (Oxford) (1990) 0.77
Cardiac ischemia. Part I--Metabolic and physiologic responses. West J Med (1987) 0.76
Hypoxic preconditioning in isolated rat hearts: non-involvement of activation of adenosine A1 receptor, Gi protein, and ATP-sensitive K+ channel. Heart Vessels (1995) 0.75
Crucial role of intracellular effectors on glycogenolysis in the isolated rat heart: potential consequences on the myocardial tolerance to ischemia. Mol Cell Biochem (1997) 0.75
The activities of fructose 1,6-diphosphatase, phosphofructokinase and phosphoenolpyruvate carboxykinase in white muscle and red muscle. Biochem J (1967) 3.14
Beta-blockers for hypertension. Cochrane Database Syst Rev (2007) 2.91
Effects of insulin on the pattern of glucose metabolism in the perfused working and Langendorff heart of normal and insulin-deficient rats. Biochem J (1969) 2.46
South African hypertension guideline 2006. S Afr Med J (2006) 2.23
Sudden death and sport. Lancet (1975) 2.14
Effects of increased heart work on glycolysis and adenine nucleotides in the perfused heart of normal and diabetic rats. Biochem J (1971) 2.04
Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet (1994) 1.99
Drugs and the heart. III. Calcium antagonists. Lancet (1980) 1.99
Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone. Am J Cardiol (1986) 1.75
Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction. Lancet (1983) 1.69
Glucose-insulin-potassium (GIK) for acute myocardial infarction: a negative study with a positive value. Cardiovasc Drugs Ther (1999) 1.63
Nifedipine and mortality. Grave defects in the dossier. Circulation (1995) 1.61
Adverse interaction between nifedipine and beta-blockade. Br Med J (1980) 1.60
Metabolism of the heart in health and disease. I. Am Heart J (1968) 1.58
Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review. Q J Med (1984) 1.43
Increased plasma-free-fatty-acid concentrations and their significance in patients with acute myocardial infarction. Lancet (1969) 1.43
Effects of glucose, insulin and potassium infusion on tissue metabolic changes within first hour of myocardial infarction in the baboon. Circulation (1975) 1.39
Protons in ischemia: where do they come from; where do they go to? J Mol Cell Cardiol (1991) 1.39
Effect of oxygenation and consequent pH changes on the efficacy of St. Thomas' Hospital cardioplegic solution. J Thorac Cardiovasc Surg (1991) 1.39
Myocardial blood flow, deoxyglucose uptake, and myocyte viability in ischemia. J Nucl Med (1992) 1.38
Antihypertensive effects of nifedipine combined with cardioselective beta-adrenergic receptor antagonism by atenolol. Am Heart J (1982) 1.28
Characterization of the "border zone" in acute regional ischemia in the dog. Am J Cardiol (1977) 1.28
Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischemia and infarct size. Am J Cardiol (1975) 1.25
Drugs and the heart. VI. Vasodilating drugs. Lancet (1980) 1.23
Drugs and the heart. Lancet (1980) 1.21
Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved. Circ Res (1996) 1.19
Biochemical aspects of arrhythmogenesis and ventricular fibrillation. Am J Cardiol (1979) 1.18
Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circ Res (1992) 1.18
Metabolic response during impending myocardial infarction. I. Relevance of studies of glucose and fatty acid metabolism in animals. Circulation (1972) 1.18
Coronary flow rate and perfusion pressure as determinants of mechanical function and oxidative metabolism of isolated perfused rat heart. J Physiol (1965) 1.16
Effects of substrates on tissue metabolic changes in the isolated rat heart during underperfusion and on release of lactate dehydrogenase and arrhythmias during reperfusion. Circ Res (1978) 1.16
Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart. Am J Cardiol (1979) 1.13
Reduction of ischemic K+ loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea. Circ Res (1990) 1.13
Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis (1989) 1.13
Metabolism of triglyceride fatty acid by the perfused rat heart. Biochem J (1967) 1.12
Pyruvate metabolism in the perfused rat heart. Am J Physiol (1963) 1.11
Adenosine cardioplegia. Adenosine versus potassium cardioplegia: effects on cardiac arrest and postischemic recovery in the isolated rat heart. J Thorac Cardiovasc Surg (1989) 1.09
The value of lactate and pyruvate measurements in the assessment of the redox state of free nicotinamide-adenine dinucleotide in the cytoplasm of perfused rat heart. Eur J Clin Invest (1971) 1.07
Effects of free fatty acid and enzyme release in experimental glucose on myocardial infarction. Nature (1975) 1.07
Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprotection. Cardiovasc Res (2000) 1.07
Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts. Circ Res (1990) 1.07
Glucose and glycogen utilisation in myocardial ischemia--changes in metabolism and consequences for the myocyte. Mol Cell Biochem (1998) 1.07
Calcium channel blockers and preconditioning. J Mol Cell Cardiol (2000) 1.06
Cyclic AMP levels in ischaemic and non-ischaemic myocardium following coronary artery ligation: relation to ventricular fibrillation. J Mol Cell Cardiol (1978) 1.06
The inhibition of skeletal-muscle fructose 1,6-diphosphatase by adenosine monophosphate. Biochem J (1967) 1.06
Drugs and the heart four years on. Lancet (1984) 1.05
Ventricular arrhythmias associated with coronary artery occlusion and reperfusion in the isolated perfused rat heart: a model for assessment of antifibrillatory action of antiarrhythmic agents. Cardiovasc Res (1978) 1.04
Experimental myocardial infarction with left ventricular failure in the isolated perfused rat heart. Effects of isoproterenol and pacing. J Mol Cell Cardiol (1975) 1.04
Effect of fatty acids on contractility and rhythm of the heart. Nature (1970) 1.03
Ventricular fibrillation threshold and vulnerable period in the isolated perfused rat heart. Cardiovasc Res (1975) 1.02
Role of cyclic nucleotides in heart metabolism. Cardiovasc Res (1982) 1.02
Drugs and the heart. IV. Antiarrhythmic agents. Lancet (1980) 1.01
The effect of alpha- and beta-adrenoceptor antagonist agents on reperfusion ventricular fibrillation and metabolic status in the isolated perfused rat heart. J Am Coll Cardiol (1983) 0.99
Is lactate-induced myocardial ischaemic injury mediated by decreased pH or increased intracellular lactate? J Mol Cell Cardiol (1995) 0.99
A role for the RISK pathway and K(ATP) channels in pre- and post-conditioning induced by levosimendan in the isolated guinea pig heart. Br J Pharmacol (2008) 0.98
Myocardial infarct size. Part I. Basic considerations. Am Heart J (1980) 0.98
Cyclic adenosine monophosphate, ventricular fibrillation, and antiarrhythmic drugs. Lancet (1976) 0.96
Myocardial infarct size. Part 2. Comparison of anti-infarct effects of beta-blockade, glucose-insulin-potassium, nitrates, and hyaluronidase. Am Heart J (1980) 0.96
Failure of high concentrations of circulating free fatty acids to provoke arrhythmias in experimental myocardial infarction. Lancet (1971) 0.96
Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart: implications for ischemic preconditioning. Basic Res Cardiol (2000) 0.95
Distribution of myocardial blood flow before and after coronary artery ligation in the baboon. Relation to early ventricular fibrillation. Cardiovasc Res (1974) 0.94
Impaired cardiac work and oxygen uptake after reperfusion of regionally ischaemic myocardium. J Mol Cell Cardiol (1979) 0.94
Adrenaline-induced "oxygen-wastage" and enzyme release from working rat heart. Effects of calcium antagonism, beta-blockade, nicotinic acid and coronary artery ligation. J Mol Cell Cardiol (1979) 0.94
Effect of alpha-adrenoceptor antagonists (phentolamine, nicergoline and prazosin) on reperfusion arrhythmias and noradrenaline release in perfused rat heart. Br J Pharmacol (1985) 0.93
Catecholamine-induced myocardial cell damage: catecholamines or adrenochrome. J Mol Cell Cardiol (1985) 0.93
Computer simulation of metabolism of glucose-perfused rat heart in a work-jump. Am J Physiol (1982) 0.92
Effect of glucose-insulin-potassium infusions on arteriovenous differences of glucose of free fatty acids and on tissue metabolic changes in dogs with developing myocardial infarction. Am J Cardiol (1976) 0.92
Effect of early oral feeding on plasma free fatty acid concentrations in patients in a coronary care unit. Br Heart J (1975) 0.92
Significance of release of adenosine triphosphate and adenosine induced by hypoxia or adrenaline in perfused rat heart. J Mol Cell Cardiol (1987) 0.92
Letter: Heart disease in marathon runners. N Engl J Med (1976) 0.91
Effects of components of ischemia and metabolic inhibition on delayed afterdepolarizations in guinea pig papillary muscle. Circ Res (1987) 0.91
Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol (2000) 0.91
Effect of glucose-insulin-potassium infusions on epicardial ECG changes and on myocardial metabolic changes after coronary artery ligation in dogs. Cardiovasc Res (1981) 0.91
Effect of increased aortic perfusion pressure on fluorescent emission of the isolated rat heart. J Mol Cell Cardiol (1974) 0.90
Drugs and the heart. V. Digitalis and sympathomimetic stimulants. Lancet (1980) 0.89
The heart in diabetes mellitus. Part II. Acute myocardial infarction and diabetes. S Afr Med J (1979) 0.89
Propranolol and experimental myocardial infarction: substrate effects. Postgrad Med J (1976) 0.89
Influence of propranolol isomers and atenolol on myocardial cyclic AMP, high energy phosphates and vulnerability to fibrillation after coronary artery ligation in the isolated rat heart. Cardiovasc Res (1981) 0.89
Catecholamine-mediated arrhythmias in acute myocardial infarction. Experimental evidence and role of beta-adrenoceptor blockade. S Afr Med J (1979) 0.89
The role of cyclic adenosine monophosphate in adrenergic effects on ventricular vulnerability to fibrillation in the isolated perfused rat heart. J Clin Invest (1978) 0.89
International Society and Federation of Cardiology: Working Group on Classification of Calcium Antagonists for Cardiovascular Disease. Am J Cardiol (1987) 0.88
Relation of cyclic nucleotide ratios to ischemic and reperfusion injury in nitric oxide-donor treated rat hearts. J Cardiovasc Pharmacol (2001) 0.88
Increased coronary venous inorganic phosphate concentrations during experimental myocardial ischemia. Am J Cardiol (1972) 0.88
Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension. Chest (1989) 0.88
Defective oxidative phosphorylation in hereditary myocardiopathy in the Syrian hamster. Cardiovasc Res (1968) 0.87
Letter: Marathon runners and impending heart-attacks. Lancet (1976) 0.87
Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors. J Am Coll Cardiol (1992) 0.87
Role of carnitine in fatty acid metabolism of normal and ischemic myocardium. Am Heart J (1979) 0.87
Calcium and catecholamines: relevance to cardiomyopathies and significance in therapeutic strategies. J Mol Cell Cardiol (1985) 0.86
Cyclic AMP as a determinant of vulnerability to ventricular fibrillation in the isolated rat heart. Cardiovasc Res (1976) 0.86
Tumor necrosis factor in myocardial hypertrophy and ischaemia--an anti-apoptotic perspective. Cardiovasc Res (2000) 0.86
Cholesterol confusion in primary prevention of coronary artery disease. Cardiovasc Drugs Ther (1993) 0.86